Kawasaki disease in Mongolia: Results from 2 nationwide retrospective surveys, 1996-2008

Journal of Epidemiology

Volumn 21, Issue 4, 2011, Pages 293-298

  Davaalkham, Dambadarjaa ^a   Nakamura, Yosikazu ^b   Baigalmaa, Davaakhuu ^c   Davaa, Gombojav ^a   Chimedsuren, Ochir ^a   Sumberzul, Nyamjav ^a   Lkhagvasuren, Tserenkhuu ^a   Uehara, Ritei ^b   Yanagawa, Hiroshi ^b   Kawasaki, Tomisaku ^d  

^a MONGOLIAN NATIONAL UNIVERSITY OF MEDICAL SCIENCES   (Mongolia)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c National Center for Communicable Diseases   (Mongolia)

^d Japan Kawasaki Disease Research Center   (Japan)

Author keywords

Children; Mongolia; Mucocutaneous lymph node syndrome; Nationwide survey

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL COMPETENCE; FEMALE; HEALTH SURVEY; HOSPITAL; HUMAN; INCIDENCE; INFANT; MALE; MONGOLIA; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; CHILD, PRESCHOOL; CLINICAL COMPETENCE; FEMALE; HEALTH SURVEYS; HOSPITALS, PEDIATRIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INCIDENCE; INFANT; MALE; MONGOLIA; MUCOCUTANEOUS LYMPH NODE SYNDROME; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 79960705026     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20100144     Document Type: Article

References (26)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: clinical observation of 50 cases. Jpn J Allerg. 1967;16:178-222.
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome prevailing in Japan. Pediatrics. 1974;54:271-6.
3. Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, et al. Kawasaki disease: A brief history. Pediatrics. 2000;106:E27.
4. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747-71.
5. Nakamura Y, Yashiro M, Uehara R, Sadakane A, Chihara I, Aoyama Y, et al. Epidemiologic features of Kawasaki disease in Japan: Results of the 2007-2008 nationwide survey. J Epidemiol. 2010;20(4):302-7.
6. Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H. Epidemiologic features of Kawasaki disease in Japan: Results from the nationwide survey in 2005-2006. J Epidemiol. 2008;18:167-72.
7. Park YW, Han JW, Park IS, Kim CH, Yun YS, Cha SH, et al. Epidemiologic picture of Kawasaki disease in Korea, 2000-2002. Pediatr Int. 2005;47:382-7.
8. Chang LY, Chang IS, Lu CY, Chiang BL, Lee CY, Chen PJ, et al; Kawasaki Disease Research Group. Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. Pediatrics. 2004;114:e678-82.
9. Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr. 2004;16:508-14.
10. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197-202.
11. Huang GY, Ma XJ, Huang M, Chen SB, Huang MR, Gui YH, et al. Epidemiologic pictures of Kawasaki disease in Shanghai from 1998 through 2002. J Epidemiol. 2006 Jan;16(1):9-14.
12. Ministry of Health, Mongolia. Health indicators 2008. Ulaanbaatar, Mongolia; 2008.
13. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int. 2005;47:232-4.
14. Shulman ST, De Inocencio J, Hirsch R. Kawasaki disease. Pediatr Clin North Am. 1995;42:1205-22.
15. Morens DM, Anderson LJ, Hurwitz ES. National surveillance of Kawasaki disease. Pediatrics. 1980;65:21-5.
16. Singh S, Gupta MK, Bansal A, Kumar RM, Mittal BR. A comparison of the clinical profile of Kawasaki disease in children from Northern India above and below 5 years of age. Clin Exp Rheumatol. 2007;25:654-7.
17. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics. 1995;95:475-9.
18. Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr. 1995;126:524-9.
19. Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr. 2000;137:250-2.
20. Chang RK. Hospitalizations for Kawasaki disease among children in the United States, 1988-1997. Pediatrics. 2002; 109:e87.
21. Momenah T, Sanatani S, Potts J, Sandor GG, Human DG, Patterson MW. Kawasaki disease in the older child. Pediatrics. 1998;102:e7.
22. Zhang T, Yanagawa H, Oki I, Nakamura Y. Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset. Acta Paediatr. 2002;91:517-20.
23. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633-9.
24. Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr. 1997;131:888-93.
25. Han RK, Sinclair B, Newman A, Silverman ED, Taylor GW, Walsh P, et al. Recognition and management of Kawasaki disease. CMAJ. 2000;162:807-12.
26. Burgner D, Harnden A. Kawasaki disease: What is the epidemiology telling us about the etiology? Int J Infect Dis. 2005;9:185-94.